Tisagenlecleucel (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tisagenlecleucel" in Spanish language version.

refsWebsite

Global rank Spanish rank

447^th place

668^th place

7^th place

15^th place

1fiercebiotech.com

low place

low place

234^th place

123^rd place

2^nd place

2^nd place

92^nd place

235^th place

1genengnews.com

low place

low place

doi.org

dx.doi.org

Ledford, Heidi (12 de julio de 2017). «Engineered cell therapy for cancer gets thumbs up from FDA advisers». Nature (en inglés). doi:10.1038/nature.2017.22304.

fda.gov

«FDA approval brings first gene therapy to the United States». FDA - U.S. Food & Drug Administration. U.S. Department of Health and Human Services. Consultado el 31 de agosto de 2017.
«BLA 125646 Tisagenlecleucel - Novartis Briefing document to FDA ODAC».
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm574058.htm

fiercebiotech.com

«Novartis gets second CAR-T candidate FDA ‘breakthrough’ tag». www.fiercebiotech.com. Fierce Biotech.

genengnews.com

«FDA Panel Unanimously Recommends Approval for Novartis' CAR T-Cell Therapy CTL019». GEN. GEN Genetic Engineering & Biotechnology News.

nature.com

Ledford, Heidi (12 de julio de 2017). «Engineered cell therapy for cancer gets thumbs up from FDA advisers». Nature (en inglés). doi:10.1038/nature.2017.22304.

npr.org

shots/2017/07/12/536812206/living-drug-that-fights-cancer-by-harnessing-the-immune-system-clears-key-hurdle «'Living Drug' That Fights Cancer By Harnessing The Immune System Clears Key Hurdle». NPR. 12 de julio de 2017. Consultado el 13 de julio de 2017.

nytimes.com

F.D.A. Approves First Gene-Altering Leukemia Treatment, Costing $475,000, By DENISE GRADY, New York Times, AUG. 30, 2017
F.D.A. Panel Recommends Approval for Gene-Altering Leukemia Treatment, By DENISE GRADY, New York Times, JULY 12, 2017
«FDA Panel Backs Novartis' Pioneering New Cancer Gene Therapy». New York Times. 12 de julio de 2017.